Jul 2024

Annegret Van der Aa CEO of Cantoni Therapeutics

We are excited to announce the appointment of Annegret Van der Aa as CEO of Cantoni Therapeutics! Annegret’s experience and skills will be highly valuable to bringing our assets to the clinic with the aim of bringing novel treatments for cardiometabolic diseases to the patient.

Back to news overview